<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Recent meta-analyses on <z:chebi fb="9" ids="16796">melatonin</z:chebi> has raised doubts as to whether <z:chebi fb="9" ids="16796">melatonin</z:chebi> is effective in treating <z:e sem="disease" ids="C0851578,C0700201" disease_type="Disease or Syndrome" abbrv="">sleep problems</z:e> in people without <z:hpo ids='HP_0001249'>intellectual disabilities</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>This is in contrast to results of several trials on <z:chebi fb="9" ids="16796">melatonin</z:chebi> in treating <z:e sem="disease" ids="C0851578,C0700201" disease_type="Disease or Syndrome" abbrv="">sleep problems</z:e> in individuals with <z:hpo ids='HP_0001249'>intellectual disabilities</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>To investigate the efficacy of <z:chebi fb="9" ids="16796">melatonin</z:chebi> in treating <z:e sem="disease" ids="C0851578,C0700201" disease_type="Disease or Syndrome" abbrv="">sleep problems</z:e> in individuals with <z:hpo ids='HP_0001249'>intellectual disabilities</z:hpo>, we performed a meta-analysis of placebo-controlled randomized trials of <z:chebi fb="9" ids="16796">melatonin</z:chebi> in individuals with <z:hpo ids='HP_0001249'>intellectual disabilities</z:hpo> and <z:e sem="disease" ids="C0851578,C0700201" disease_type="Disease or Syndrome" abbrv="">sleep problems</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Data were selected from articles published on PubMed, Medline, and Embase between January 1990 and July 2008 </plain></SENT>
<SENT sid="4" pm="."><plain>We examined the influence of <z:chebi fb="9" ids="16796">melatonin</z:chebi> on sleep latency, total sleep time, and number of wakes per night </plain></SENT>
<SENT sid="5" pm="."><plain>Quality of trials was assessed using the Downs and Black checklist </plain></SENT>
<SENT sid="6" pm="."><plain>Nine studies (including a total of 183 individuals with <z:hpo ids='HP_0001249'>intellectual disabilities</z:hpo>) showed that <z:chebi fb="9" ids="16796">melatonin</z:chebi> treatment decreased sleep latency by a mean of 34 minutes (p&lt;0.001), increased total sleep time by a mean of 50 minutes (p&lt;0.001), and significantly decreased the number of wakes per night (p&lt;0.05) </plain></SENT>
<SENT sid="7" pm="."><plain><z:chebi fb="9" ids="16796">Melatonin</z:chebi> decreases sleep latency and number of wakes per night, and increases total sleep time in individuals with <z:hpo ids='HP_0001249'>intellectual disabilities</z:hpo> </plain></SENT>
</text></document>